WAM
ONC icon

Wealthspire Advisors (Maryland)’s BeOne Medicines Ltd ONC Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-60
Closed -$8K – 2120
2019
Q1 		$8K Hold
60
– – ﹤0.01% 1645
2018
Q4 		$8K Buy
+60
New +$7.96K ﹤0.01% 1578

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ONC Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of BeOne Medicines Ltd (ONC) in Q2 2019, closing a stake of 60 shares — an estimated $8K sold.

Wealthspire Advisors (Maryland) first reported a position in ONC in Q4 2018 and held it in 2 quarters. The position peaked at $8K in Q1 2019. 203 funds tracked by Wall St. Rank hold ONC as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining BeOne Medicines Ltd position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 60 BeOne Medicines Ltd shares in Q2 2019, an estimated $8K.
  • Wealthspire Advisors (Maryland) first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 2 quarters.
  • Wealthspire Advisors (Maryland)'s BeOne Medicines Ltd position peaked at $8K in Q1 2019.
  • 203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.